3 E Network Technology Group Ltd
MASKAbout the company
3 E Network Technology Group Limited, through its subsidiaries, engages in the provision of business-to-business information technology (IT) solutions for companies in the People's Republic of China. It offers smart property and restaurant management software systems; and clean energy related software.
Investment snapshot
Positive
4
BUY / PASS
Neutral / negative
2 / 10
NEUTRAL / FAIL
Median fair value
$1.45
-19.4% vs price
Models with upside
0 / 17
Positive margin of safety
Strongest signal
6 of 8 pass — Greenblatt and Akre object
Key risk
MASK overvalued: all 7 models price fair value below $1.80 (median $1.45)
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | Not ranked | PASS | FAIL | PASS | FAIL | PASS | FAIL | FAIL | FAIL | PASS | NEUTRAL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||
| Margin of Safety | -102.2% | N/A | N/A | -55.2% | N/A | -24.1% | N/A | -350.0% | -21.6% | -23.3% | N/A | -23.3% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2024 Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Annual history · FY 2024 · Market data at 2026-11-01 Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2024 Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Annual history · FY 2024 · Market data at 2026-11-01 Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Annual history · FY 2024 · Qualitative assessment Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Annual history · FY 2024 Latest source filing: 2025-11-14 Score computed: 2026-11-14 | Annual history · FY 2024 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-11-14 Score computed: 2026-11-14 |
Where It Passes
- Efficiency75% pass✓ 9✗ 2▾
6 of 8 pass — Greenblatt and Akre object
Current Ratio2.46✓Graham>= 2.0ROIC (3-5 yr avg)21.9%✓Buffett> 10%ROIC - WACC+11.9%✓BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)✗Greenblatt> 25%Current Ratio Change YoY1.98 -> 2.46✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.22x -> 0.52x✓PiotroskiImproved YoYCurrent Assets / Current Liabilities2.46✓Dreman> 1.5Return on Invested Capital19.2%✓Munger> 15%ROIC (high and growing)FY2022: ROIC=unavailable; FY2023: ROIC=23.6%; FY2024: ROIC=19.2%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC19.2% (RR=100% x ROIC=19.2%)✓AkreReinvestment Rate * ROIC > 10%ROIC (5-year)2/2 years above 12% (latest 19.2%)✓SleepROIC > 12% in a majority of years
Where It Falls Short
- Valuation models0% pass✗ 7▾
MASK overvalued: all 7 models price fair value below $1.80 (median $1.45)
Graham fair value$0.89✗Graham-102.2% margin vs $1.80Greenblatt fair value$1.16✗Greenblatt-55.2% margin vs $1.80Dreman fair value$1.45✗Dreman-24.1% margin vs $1.80Pabrai fair value$0.40✗Pabrai-350.0% margin vs $1.80Akre fair value$1.48✗Akre-21.6% margin vs $1.80Marks fair value$1.46✗Marks-23.3% margin vs $1.80Templeton fair value$1.46✗Templeton-23.3% margin vs $1.80 - Valuation8% pass✓ 4✗ 24▾
12 of 13 flag MASK's valuation — Graham, Lynch, Greenblatt +9 more
Price / 3-yr avg EPS16.9x✗Graham<= 15xPrice-to-Book Ratio3.6x✗Graham<= 1.5xP/E x P/B60.10✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)P/E 25.7x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value41.7%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=41.7%, ROC=None✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS25.7x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)1379.1x✗Dreman< 8xPrice / Book Value per Share3.6x✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessP/E=25.7x✗MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=25.7x✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=25.7x, P/B=3.6x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-12.5% (IV=$1.60 vs Price=$1.80)✗Marks>= 20% below intrinsic valuePrice / FCF per Share✗Ackman<= 25Price vs. Trailing Low254% of trailing low ($0.71)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization+32.36%; #186/6340 (top 2.9%)✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+2.2646; #598/6449 (top 9.3%)✓AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS25.7x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share3.56x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+2.0453; #1063/5247 (top 20.3%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date+21.62%; #1277/6202 (top 20.6%)✗OshaughnessyTop 10% of eligible cross-section - Cash Flow10% pass✓ 2✗ 10▾
9 of 10 flag MASK's cash flow — Buffett, Lynch, Piotroski +6 more
Free Cash Flow Proxy✗BuffettPositive and growingFCF Positive and Growing✗LynchPositive and growingOperating Cash Flow$0.0M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=0.15%, ROA=8.18%✗PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)1379.1x✗Dreman< 8xP/E or FCF YieldP/E=25.7x✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive✗MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap✗Ackman>= 4%Price / FCF per Share✗Ackman<= 25Positive Operating Cash Flow frequency3/3 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures✗Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization✗OshaughnessyTop 10% of eligible cross-section - Growth13% pass✓ 4✗ 9▾
7 of 8 flag MASK's growth — Graham, Lynch, Dreman +4 more
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)P/E 25.7x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-16.3%✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthN/A (no inventory)✓LynchInventory growth < Revenue growthEPS Growth Direction$0.10 (2022) -> $0.07 (2024)✗DremanPositive over recent yearsEPS CAGR-16.3% CAGR over 2 years✗Dreman> 5% annualizedPositive Net Income Frequency3/3 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth1338.5%✓Ackman>= 5%Positive EPS Growth Frequency1/2 years with positive EPS growth✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 80.2% -> 49.8%, operating margin 48.6% -> 39.9%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR1041.2%✓SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Profitability19% pass✓ 11✗ 24▾
13 of 16 flag MASK's profitability — Graham, Buffett, Lynch +10 more
Positive EPS (10 years)3/3 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)3/3 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)35.4%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy✗BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)P/E 25.7x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-16.3%✗Lynch15-30% (Fast Grower); > 0% to passROE14.3%✗Lynch> 15%EBIT / Enterprise Value41.7%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=41.7%, ROC=None✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets8.18%✓PiotroskiROA > 0ROA Change YoY40.11% -> 8.18% (delta: -31.93%)✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=0.15%, ROA=8.18%✗PiotroskiCFO/Assets > ROAGross Margin Change YoY96.4% -> 49.8%✗PiotroskiImproved YoYPre-Tax Income / Revenue39.5%✓Dreman>= 8%Net Income / Shareholders' Equity14.3%✓Dreman> 12%Margin of SafetyP/E=25.7x, P/B=3.6x✗PabraiP/B < 1.5 or P/E < 15Return on Equity35.4% (3-yr avg)✓AkreROE > 20% (3-year avg)Discount to Intrinsic Value-12.5% (IV=$1.60 vs Price=$1.80)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency3/3 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue39.9%✓Ackman>= 15%Net Income / Shareholders Equity14.3%✗Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend48.6% (2022) -> 39.9% (2024)✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 80.2% -> 49.8%, operating margin 48.6% -> 39.9%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization+32.36%; #186/6340 (top 2.9%)✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+25.75%; #1668/3702 (top 45.1%)✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity+14.29%; #1232/5226 (top 23.6%)✓AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years✗Schloss>= 70% positive over 5-10 observed years (app rule) - Verdicts29% pass✓ 4✗ 10▾
Split decision: 10 FAIL · 4 PASS · 2 NEUTRAL
Overall verdict✗GrahamFAIL (1/9)✗BuffettFAIL (3/9)✗LynchFAIL (1/7)•GreenblattNot ranked✓PiotroskiPASS (F-Score 5)✗DremanFAIL (4/11)✓MungerPASS (2/4)✗PabraiFAIL (0/3)✓AkrePASS (3/6)✗MarksFAIL (1/5)✗AckmanFAIL (3/9)✗TempletonFAIL (2/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (0/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked) - Debt & Leverage50% pass✓ 8✗ 7▾
6 of 12 pass — Graham, Buffett, Lynch +3 more object
Debt Levels0.48✓MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3LT Debt vs Net Current Assets✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.48, IC: N/A✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.48✗Lynch< 0.33Cash - Long-term Debt✗LynchPositive preferredLT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities2.46✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.48✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xInterest Coverage & Debt/EBITDA✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.48✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.4820; #2434/4210 (top 57.8%)✗AsnessTop 30% of eligible cross-section
Business & financials
Financial snapshot: annual FY 2024. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2024
Issued 6.0% of shares last year, 6.0% issued over two.
- Buybacks
- —
- Dividends
- —
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
| Metric | FY 2024Sources
| FY 2023Sources
| FY 2022Sources
|
|---|---|---|---|
| Market Cap | $2.4Mcurrent | $715.0Mest. | -- |
| Revenue | $4.8M↑463% | $859.3K↑2214% | $37.1K |
| Operating Income | $1.9M↑136% | $817.6K↑4435% | $18.0K |
| Net Income | $764.9K↓51% | $1.5M↑55% | $996.2K |
| EPS (Diluted) | $0.07↓53% | $0.15↑50% | $0.10 |
| Gross Margin | 49.8%↓48% | 96.4%↑20% | 80.2% |
| Operating Margin | 39.9%↓58% | 95.1%↑96% | 48.6% |
| ROE | 14.3%↓75% | 56.6% | — |
| Total Debt | $2.6M | $0 | -- |
| Shareholders' Equity | $5.4M↑96% | $2.7M | -- |
| Current Ratio | 2.46↑24% | 1.98 | — |
| Debt / Equity | 0.48 | 0.00 | — |
| Operating Cash Flow | $13.8K↓99% | $929.2K↑3% | $901.3K |
| Free Cash Flow | -- | -- | -- |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Business Services
MASK vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AUTOMATIC DATA PROCESSING INCADP | $122.3B | $309.93 | $21.9B | $4.4B | 73.2% | 0.82 | 24.2% | 1.05 | 4/9 | 5/9 | 3/7 | 0/3 | F-Score 6 | 5/11 |
| ELECTRONIC ARTS INC.EA | $52.9B | $209.70 | $7.5B | $887.0M | 13.1% | 0.22 | 15.4% | 1.05 | 1/9 | 4/9 | 4/7 | 0/3 | F-Score 6 | 6/11 |
| Rubrik, Inc.RBRK | $22.6B | $109.88 | $1.3B | $348.8M | 67.1% | — | -26.2% | 1.69 | 1/9 | 0/9 | 2/7 | 0/3 | F-Score 6 | 2/11 |
| AECOMACM | $9.1B | $70.50 | $16.1B | $561.8M | 22.5% | 1.09 | 6.4% | 1.14 | 1/9 | 3/9 | 3/7 | 1/3 | F-Score 8 | 2/11 |
| COMMVAULT SYSTEMS INCCVLT | $6.2B | $152.07 | $1.2B | $70.7M | 942.8% | — | 6.3% | 1.95 | 1/9 | 2/9 | 4/7 | 0/3 | F-Score 6 | 6/11 |
| WPP plcWPP | $6.0B | $27.79 | $18.2B | $289.5M | -8.5% | 1.94 | 2.8% | 0.89 | 1/9 | 2/9 | 1/7 | 0/3 | F-Score 3 | 2/11 |
| VARONIS SYSTEMS INCVRNS | $5.6B | $48.94 | $623.5M | $129.3M | -21.6% | 0.76 | -23.5% | 1.97 | 1/9 | 0/9 | 1/7 | 0/3 | F-Score 5 | 1/11 |
| ROBERT HALF INC.RHI | $4.3B | $42.00 | $5.4B | $133.0M | 10.4% | — | 1.4% | 1.53 | 2/9 | 5/9 | 1/7 | 0/3 | F-Score 5 | 2/11 |